000 02545nam  2200325zi 4500
0019.933488
003CaOODSP
00520240307134648
006m     o  d f      
007cr cn|||||||||
008240205s2016    onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-211/2016E-PDF
24500|aEvaluation of immunization and respiratory infectious disease activities at the Public Health Agency of Canada, 2011-2012 to 2015-2016 / |cprepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.
264 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |c2016.
300 |a1 online resource (xi, 60 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Évaluation des activités liées à l’immunisation et aux maladies respiratoires infectieuses à l’Agence de la santé publique du Canada de 2011-2012 à 2015-2016.
504 |aIncludes bibliographical references (pages 55-60).
520 |a"The purpose of the evaluation was to assess the relevance and performance of the Public Health Agency of Canada (PHAC)'s Immunization and Respiratory Infectious Disease Activities. The scope of the evaluation covered the period from April 2011 to March 2016 and included various PHAC activities such as National Immunization Strategy leadership and coordination; vaccine guidance; public and professional education and outreach to promote vaccine acceptance and uptake; security of vaccine supply; surveillance and epidemiology; coordinated immunization research, vaccine innovation and development; pandemic preparedness and coordinated outbreak response"--Executive summary, page ii.
61020|aPublic Health Agency of Canada|xEvaluation.
650 0|aPreventive health services|zCanada|xEvaluation.
650 0|aPublic health|zCanada|xEvaluation.
7102 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body.
7101 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation.
77508|tÉvaluation des activités liées à l’immunisation et aux maladies respiratoires infectieuses à l’Agence de la santé publique du Canada de 2011-2012 à 2015-2016 / |w(CaOODSP)9.934992
85640|qPDF|s1.27 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-211-2016-eng.pdf